← FDA Drug Approvals (Drugs@FDA)

DARUNAVIR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2017-11-21

Drug application

FDA Application #

ANDA202118

Application type

Abbreviated New Drug Application (Generic)

Brand name

DARUNAVIR

Generic name

Darunavir

Active ingredients

DARUNAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

TEVA PHARMS USA

First approval

2017-11-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown